Mondaq Asia Pacific - India: Food, Drugs, Healthcare, Life Sciences
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
Nishith Desai Associates
The Indian Government has had a busy 2019 so far with respect to healthcare regulation. From passing the controversial National Medical Commission Act, 2019 through
AMLEGALS
The focus of the regulation is to make the Companies accountable for their claims on food products and cater to the interest of customers.
Cyril Amarchand Mangaldas
In the backdrop of recent attacks and acts of violence against medical practitioners and a growing demand for protection in this regard
Cyril Amarchand Mangaldas
The National Medical Commission Act, 2019 (NMC Act) has been notified vide the Gazette Notification dated August 8, 2019.
Nishith Desai Associates
Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
S.S. Rana & Co. Advocates
But the treating doctor called back the Complainant only at 10.30 p.m. as she was out of station.
S.S. Rana & Co. Advocates
Cannabis, also known as ‘marijuana' among other names is a psychoactive drug from the Cannabis plant used for medical or recreational purposes.
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
Obhan & Associates
Evidence from DNA fingerprinting tests can be used to determine disputes involving plant varieties, according to a recent decision of the Delhi High Court. In its recent judgment
AZB & Partners
Some authorities have issued separate handbooks in the context of the leased lands, which impose additional restrictions as well.
AZB & Partners
On June 20, 2019, CCI penalised Jalgaon District Medicine Dealers Association (‘JDMDA') as well as its office bearers, i.e., the President and Secretary of JDMDA
AZB & Partners
On May 22, 2019, CCI approved the merger of certain consumer healthcare products of GlaxoSmithKline Plc. (‘GSK') and Pfizer Inc. (‘Pfizer', together with GSK
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
SKP Business Consulting LLP
India is one of the world's largest seafood producers and top exporter of fish and fish products to the major developed markets of the world such as US
Singh & Associates
FDA Finalizes guidance for premarket tobacco product applications to check oversight of tobacco products and health issue
Singh & Associates
This segment of the newsletter is focused on regulatory reforms from Healthcare and Pharmaceutical sectors in the Indian jurisdiction with collated information on monthly basis via c
Singh & Associates
Impact of ENDS on Public Health ENDS or e-cigarettes are battery operated smoking devices.
LexOrbis
The US Food and Drug Administration (FDA) has over the years come up with initiatives to protect the interests of both the patented and generic drug manufacturers.
Singh & Associates
On June 17, 2019, a report on ‘The Indian pharmaceutical industry – the way forward' was published by an Indian Pharmaceutical Alliance representing research based pharmaceutical companies ...
Latest Video
Most Popular Recent Articles
Singh & Associates
The Indian Pharmacopoeia Commission (IPC) has released the Eighth Edition of Indian Pharmacopoeia (IP-2018). It was released by the Secretary, Ministry of Health & Family Welfare, Government of India.
Cyril Amarchand Mangaldas
Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
Singh & Associates
On June 17, 2019, a report on ‘The Indian pharmaceutical industry – the way forward' was published by an Indian Pharmaceutical Alliance representing research based pharmaceutical companies ...
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Singh & Associates
This segment of the newsletter is focused on regulatory reforms from Healthcare and Pharmaceutical sectors in the Indian jurisdiction with collated information on monthly basis via c
SKP Business Consulting LLP
India is one of the world's largest seafood producers and top exporter of fish and fish products to the major developed markets of the world such as US
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Obhan & Associates
Evidence from DNA fingerprinting tests can be used to determine disputes involving plant varieties, according to a recent decision of the Delhi High Court. In its recent judgment
Singh & Associates
The Pharmacovigilance Programme of India, was first introduced in the year 2010 to improve safety of Indian population by monitoring drug related Adverse Drug Reactions collected via ADR monitoring centers ...
Singh & Associates
FDA Finalizes guidance for premarket tobacco product applications to check oversight of tobacco products and health issue
Singh & Associates
Impact of ENDS on Public Health ENDS or e-cigarettes are battery operated smoking devices.
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with